Wednesday 13 January, 2010
Skyepharma PLC
Holding(s) in Company
RNS Number : 5208F Skyepharma PLC 13 January 2010
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
|
SkyePharma Plc
|
|
2 Reason for the notification (please tick the appropriate box or boxes):
|
|
An acquisition or disposal of voting rights
|
|
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
|
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
|
|
|
An event changing the breakdown of voting rights
|
|
|
Other (please specify):
|
Delta adjustment
|
X
|
|
3. Full name of person(s) subject to the notification obligation:
|
D.E. Shaw & Co., L.P.
D.E. Shaw & Co. (U.K.), Ltd.
|
|
4. Full name of shareholder(s) (if different from 3.):
|
N/A
|
|
5. Date of the transaction and date on which the threshold is crossed or reached:
|
January 11, 2010
|
|
6. Date on which issuer notified:
|
January 13, 2010
|
|
7. Threshold(s) that is/are crossed or reached:
|
32%
|
|
8. Notified details:
|
|
A: Voting rights attached to shares
|
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering transaction
|
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
% of voting rights
|
|
Direct
|
Direct
|
Indirect
|
Direct
|
Indirect
|
|
|
|
|
|
|
|
|
|
|
|
|
B: Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Expiration
date
|
Exercise/ Conversion Period
|
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
|
% of voting
rights
|
|
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Exercise
price
|
Expiration
date
|
Exercise/
Conversion
period
|
Number of voting
rights instrument
refers to
|
% of voting rights
|
|
Contract for Differences ("CfD") relating to convertible bond due 2024
|
|
March 4, 2010
|
|
3,461,725
|
Nominal
|
Delta
|
|
|
14.46%
|
|
CfD relating to convertible bond due 2025
|
|
December 3, 2010
|
|
2,058,916
|
Nominal
|
Delta
|
|
|
8.60%
|
|
CfD relating to convertible bond due 2025
|
|
June 3, 2010
|
|
2,058,916
|
Nominal
|
Delta
|
|
|
8.60%
|
|
Total (A+B+C)
|
|
Number of voting rights
|
Percentage of voting rights
|
|
7,579,557
|
31.66%
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
|
|
Each of D.E. Shaw & Co., L.P. ("DESCO LP") and D.E. Shaw & Co. (U.K.), Ltd. ("DESCO UK") is notifying solely in its capacity as a discretionary investment manager. As general partner of DESCO LP, D.E. Shaw & Co., Inc. ("DESCO Inc.") is a parent undertaking of DESCO LP and DESCO UK. By virtue of David E. Shaw's position as president and sole shareholder of DESCO, Inc., which is the general partner of DESCO LP, David E. Shaw is a parent undertaking of DESCO LP and DESCO UK.
|
|
Proxy Voting:
|
|
10. Name of the proxy holder:
|
|
|
11. Number of voting rights proxy holder will cease to hold:
|
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
|
|
13. Additional information:
|
|
|
14. Contact name:
|
Stephen Back (Compliance Department)
|
|
15. Contact telephone number:
|
+1 212-478-0000
|
This information is provided by RNS
The company news service from the London Stock Exchange END HOLDXLFFBFFLBBD
|
|